Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer

Clinical trial NCT03286244 · UNKNOWN

Trial details

NCT number: NCT03286244
Sponsor: AnewPharma
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Gastric Cancer

Start date: 2018-03-15
Primary completion: 2019-08-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.